New Amsterdam Partners Holding in Pbf Energy Cl A (PBF) Trimmed by $1.24 Million as Stock Declined; Lilly Eli & Co Com (LLY) Shareholder Private Capital Advisors Has Lowered Its Stake by $10.70 Million as Stock Price Rose

Eli Lilly and Company (NYSE:LLY) Logo

New Amsterdam Partners Llc decreased its stake in Pbf Energy Inc Cl A (PBF) by 12.12% based on its latest 2018Q3 regulatory filing with the SEC. New Amsterdam Partners Llc sold 25,359 shares as the company’s stock declined 35.95% with the market. The institutional investor held 183,856 shares of the integrated oil company at the end of 2018Q3, valued at $9.18M, down from 209,215 at the end of the previous reported quarter. New Amsterdam Partners Llc who had been investing in Pbf Energy Inc Cl A for a number of months, seems to be less bullish one the $4.37B market cap company. The stock increased 2.62% or $0.92 during the last trading session, reaching $36.1. About 1.58 million shares traded. PBF Energy Inc. (NYSE:PBF) has declined 0.70% since February 14, 2018 and is downtrending. It has underperformed by 0.70% the S&P500. Some Historical PBF News: 03/05/2018 – PAULSBORO REFINERY COKER, SMALL CRUDE UNIT WORK STARTS SEPT:PBF; 03/05/2018 – PBF ENERGY BEGINS 1Q EARNINGS CONFERENCE CALL; 14/05/2018 – Baupost Adds PG&E, Exits Express Scripts, Cuts PBF Energy: 13F; 16/04/2018 – PBF LOGISTICS LP – DEAL FOR TOTAL CONSIDERATION OF $125.4 MLN, INCLUDING ACQUISITIONS AND INVESTMENTS; 19/04/2018 – PBF Energy partially shuts sulfur plant at Delaware City refinery; 03/05/2018 – DELAWARE CITY REFINERY REFORMER WORK SET FOR NOVEMBER: PBF; 12/04/2018 – PBF ENERGY CHALMETTE LOUISIANA REFINERY RESTARTING GASOLINE UNIT; 08/05/2018 – PBF HOLDING COMPANY LLC SAYS ON MAY 2, ENTERED INTO A NEW ASSET-BASED REVOLVING CREDIT AGREEMENT – SEC FILING; 31/05/2018 – EXCLUSIVE-U.S. EPA AWARDS SINCLAIR OIL, HOLLYFRONTIER MILLIONS OF DOLLARS IN BIOFUELS CREDITS FOR WAIVER DENIALS -SOURCES, FILINGS; 08/05/2018 – PBF ENERGY IN NEW ASSET-BASED REVOLVING CREDIT PACT

Private Capital Advisors Inc decreased its stake in Lilly Eli & Co Com (LLY) by 25.94% based on its latest 2018Q3 regulatory filing with the SEC. Private Capital Advisors Inc sold 100,000 shares as the company’s stock rose 7.21% while stock markets declined. The hedge fund held 285,549 shares of the major pharmaceuticals company at the end of 2018Q3, valued at $30.64M, down from 385,549 at the end of the previous reported quarter. Private Capital Advisors Inc who had been investing in Lilly Eli & Co Com for a number of months, seems to be less bullish one the $120.69B market cap company. The stock increased 0.13% or $0.16 during the last trading session, reaching $119.65. About 12.74M shares traded or 137.35% up from the average. Eli Lilly and Company (NYSE:LLY) has risen 32.86% since February 14, 2018 and is uptrending. It has outperformed by 32.86% the S&P500. Some Historical LLY News: 26/03/2018 – Bristol-Myers Squibb Receives Positive CHMP Opinion Recommending Approval of Opdivo Four-Week Dosing Schedule for Advanced; 10/05/2018 – Lilly to buy Armo Biosciences for $1.6 bln; 23/04/2018 – Elanco Animal Health, a Division of Eli Lilly, Named Christopher Jensen as CFO; 24/04/2018 – Eli Lilly Sees 2018 Effective Tax Rate About 17%; 09/04/2018 – KEYTRUDA® (PEMBROLIZUMAB) MONOTHERAPY MET PRIMARY ENDPOINT IN PHASE 3 KEYNOTE-042 STUDY, SIGNIFICANTLY IMPROVING OS AS FIRST-LINE THERAPY IN LOCALLY ADVANCED OR METASTATIC NSCLC PATIENTS EXPRESSING P…; 24/04/2018 – Eli Lilly Raises 2018 R&D Expenses View to $5.2B-$5.4B; 06/03/2018 – Bristol-Myers: FDA Approves Supplemental Biologics License Application Updating Opdivo Dosing Schedul; 16/05/2018 – NOVARTIS AG NOVN.S CEO SAYS CONTINUES TO BELIEVE KISQUALI IMPORTANT BUT NOT AS LARGE AS ONCE THOUGHT; 17/05/2018 – Oncolytics Biotech® Announces Collaboration with Merck and Northwestern University Combining Keytruda® and REOLYSIN® in a Phase 2 Second Line Pancreatic Cancer Study; 30/04/2018 – Merck: FDA Grants Priority Review to sBLA for Keytruda Combination

More notable recent Eli Lilly and Company (NYSE:LLY) news were published by: Seekingalpha.com which released: “Eli Lilly Surges On Pipeline News: Analysis And Trading Thoughts – Seeking Alpha” on October 08, 2018, also Streetinsider.com with their article: “Eli Lilly & Co. (LLY), Incyte Corporation (INCY) Report Top-Line Phase 3 Results for Baricitinib in Patients with Moderate to Severe Atopic Dermatitis – StreetInsider.com” published on February 04, 2019, Streetinsider.com published: “Lilly’s (LLY) Phase 3 Soft Tissue Sarcoma Study of LARTRUVO Did Not Meet Primary Endpoints – StreetInsider.com” on January 18, 2019. More interesting news about Eli Lilly and Company (NYSE:LLY) were released by: Streetinsider.com and their article: “Lilly (LLY) Announces FDA Expanded its ALIMTA Label with Combination of KEYTRUDA and Platinum Chemotherapy for First-Line Treatment of Metastatic Nonsquamous NSCLC – StreetInsider.com” published on January 31, 2019 as well as Seekingalpha.com‘s news article titled: “Treatment with Lilly’s Lartruvo to cease in Europe – Seeking Alpha” with publication date: January 23, 2019.

Investors sentiment increased to 0.98 in 2018 Q3. Its up 0.14, from 0.84 in 2018Q2. It is positive, as 37 investors sold LLY shares while 399 reduced holdings. 141 funds opened positions while 286 raised stakes. 794.28 million shares or 1.80% less from 808.82 million shares in 2018Q2 were reported. 2,470 were reported by Forbes J M And Com Limited Liability Partnership. Zurcher Kantonalbank (Zurich Cantonalbank) holds 223,904 shares or 0.2% of its portfolio. Boston Llc reported 96,373 shares stake. Town And Country Bancorp And Tru Dba First Bankers Tru stated it has 2.14% in Eli Lilly and Company (NYSE:LLY). Gamble Jones Counsel invested in 0.16% or 16,119 shares. Evergreen Cap Management Ltd Llc owns 2,644 shares. Trustmark National Bank Trust Department has 11,072 shares for 0.08% of their portfolio. Stewart Patten Com Ltd holds 0.18% or 8,931 shares. Price T Rowe Associate Md reported 0.09% stake. 373,459 are owned by Grantham Mayo Van Otterloo & Ltd Liability Com. Moreover, Hartford Investment Communication has 0.38% invested in Eli Lilly and Company (NYSE:LLY). Bb&T Llc has 156,724 shares for 0.17% of their portfolio. Mitchell Mcleod Pugh Williams Incorporated holds 9,117 shares or 0.66% of its portfolio. Plancorp Ltd Liability Corporation has invested 0.41% in Eli Lilly and Company (NYSE:LLY). The Massachusetts-based Massachusetts Services Ma has invested 0.21% in Eli Lilly and Company (NYSE:LLY).

Private Capital Advisors Inc, which manages about $362.28 million US Long portfolio, upped its stake in Blackstone Mortgage Trust Inc (NYSE:BXMT) by 27,827 shares to 188,115 shares, valued at $6.30M in 2018Q3, according to the filing. It also increased its holding in Mplx Lp (NYSE:MPLX) by 80,901 shares in the quarter, for a total of 241,542 shares, and has risen its stake in At&T Inc (NYSE:T).

Since August 15, 2018, it had 0 insider purchases, and 26 sales for $285.41 million activity. Another trade for 600 shares valued at $63,342 was sold by Zakrowski Donald A. 7,000 Eli Lilly and Company (NYSE:LLY) shares with value of $802,480 were sold by Zulueta Alfonso G. O’Neill Myles sold 25,000 shares worth $2.82 million.

Among 25 analysts covering Eli Lilly and Company (NYSE:LLY), 13 have Buy rating, 0 Sell and 12 Hold. Therefore 52% are positive. Eli Lilly and Company had 124 analyst reports since July 23, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Monday, June 5 by Jefferies. The stock of Eli Lilly and Company (NYSE:LLY) has “Equal-Weight” rating given on Tuesday, July 31 by Morgan Stanley. On Friday, April 7 the stock rating was maintained by Barclays Capital with “Overweight”. The firm has “Buy” rating given on Tuesday, August 2 by Argus Research. As per Friday, September 8, the company rating was maintained by Piper Jaffray. On Wednesday, July 25 the stock rating was maintained by Credit Suisse with “Underperform”. Goldman Sachs downgraded the stock to “Hold” rating in Tuesday, January 16 report. The company was maintained on Monday, August 24 by Cowen & Co. The stock of Eli Lilly and Company (NYSE:LLY) earned “Sell” rating by BMO Capital Markets on Wednesday, August 16. As per Tuesday, January 16, the company rating was maintained by Jefferies.

New Amsterdam Partners Llc, which manages about $389.50M US Long portfolio, upped its stake in Exlservice Holdings Inc (NASDAQ:EXLS) by 28,356 shares to 86,231 shares, valued at $5.71 million in 2018Q3, according to the filing. It also increased its holding in Knoll Inc (NYSE:KNL) by 43,126 shares in the quarter, for a total of 274,988 shares, and has risen its stake in Cirrus Logic Inc (NASDAQ:CRUS).

More notable recent PBF Energy Inc. (NYSE:PBF) news were published by: Seekingalpha.com which released: “PBF Logistics Q4 2018 Earnings Preview – Seeking Alpha” on February 13, 2019, also Seekingalpha.com with their article: “Trump administration considering Venezuela oil sanctions – Platts – Seeking Alpha” published on January 16, 2019, Globenewswire.com published: “Factors of Influence in 2019, Key Indicators and Opportunity within Helmerich & Payne, Genworth Financial, PBF Energy, EastGroup Properties, Helix Energy, and The Clorox — New Research Emphasizes Economic Growth – GlobeNewswire” on February 08, 2019. More interesting news about PBF Energy Inc. (NYSE:PBF) were released by: Seekingalpha.com and their article: “PBF Energy’s Integrated Success Creating Value – Seeking Alpha” published on February 11, 2019 as well as Seekingalpha.com‘s news article titled: “U.S. launches sanctions against Venezuela’s PDVSA oil firm – Seeking Alpha” with publication date: January 28, 2019.

Among 20 analysts covering PBF Energy Inc (NYSE:PBF), 6 have Buy rating, 3 Sell and 11 Hold. Therefore 30% are positive. PBF Energy Inc had 82 analyst reports since July 24, 2015 according to SRatingsIntel. As per Monday, April 16, the company rating was maintained by Morgan Stanley. As per Tuesday, August 11, the company rating was downgraded by Zacks. PiperJaffray reinitiated PBF Energy Inc. (NYSE:PBF) on Thursday, January 10 with “Overweight” rating. The firm has “Hold” rating given on Wednesday, December 20 by RBC Capital Markets. Morgan Stanley upgraded the shares of PBF in report on Friday, January 15 to “Overweight” rating. Morgan Stanley upgraded it to “Overweight” rating and $48 target in Wednesday, January 9 report. The rating was maintained by RBC Capital Markets with “Hold” on Thursday, July 6. J.P. Morgan downgraded it to “Sell” rating and $31.0 target in Tuesday, December 12 report. The firm earned “Sell” rating on Friday, September 9 by Goldman Sachs. The firm earned “Hold” rating on Tuesday, January 30 by RBC Capital Markets.

Eli Lilly and Company (NYSE:LLY) Institutional Positions Chart